Product Information
ROPINIROLE HCL 0.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0435 per EA under NDC 62332003131. Its NADAC has been published 529 times since May 11, 2016.
Strength
.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003131
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090429On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.5 MG TABLET has been published 529 times since May 11, 2016, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0435 per EA |
|---|---|
| All-time high | $0.0985 (May 11, 2016) |
| All-time low | $0.0347 (Nov 20, 2024) |
| 52-week high | $0.0467 |
| 52-week low | $0.0426 |
| Median price | $0.0567 |
| Average price | $0.0571 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 529 |
| Tracking since | May 11, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ROPINIROLE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0435 per EA (NDC 62332003131), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.5 MG TABLET has declined 55.9%. It has been tracked across 529 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.5 MG TABLET?
Since May 11, 2016, the NADAC for ROPINIROLE HCL 0.5 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.0985 (May 11, 2016), with a median of $0.0567 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ROPINIROLE HCL 0.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL 0.5 MG TABLET?
ROPINIROLE HCL 0.5 MG TABLET (NDC 62332003131) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification